96 related articles for article (PubMed ID: 1731036)
1. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
Ayesta FJ; Ableitner A; Emmett-Oglesby MW; Herz A; Shippenberg TS
J Pharmacol Exp Ther; 1992 Jan; 260(1):168-74. PubMed ID: 1731036
[TBL] [Abstract][Full Text] [Related]
2. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
Walker EA; Makhay MM; House JD; Young AM
J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.
Adams JU; Holtzman SG
J Pharmacol Exp Ther; 1990 May; 253(2):483-9. PubMed ID: 2338644
[TBL] [Abstract][Full Text] [Related]
4. Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.
White DA; Holtzman SG
J Pharmacol Exp Ther; 2001 Jul; 298(1):156-64. PubMed ID: 11408537
[TBL] [Abstract][Full Text] [Related]
5. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
Holtzman SG
J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
7. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
Millan MJ; Morris BJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.
France CP; Gerak LR; Flynn D; Winger GD; Medzihradsky F; Bagley JR; Brockunier LL; Woods JH
J Pharmacol Exp Ther; 1995 Jul; 274(1):17-28. PubMed ID: 7616395
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
10. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
Negus SS; Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
[TBL] [Abstract][Full Text] [Related]
11. Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
France CP; Woods JH
J Pharmacol Exp Ther; 1988 Feb; 244(2):599-605. PubMed ID: 3346837
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.
Tempel A; Gardner EL; Zukin RS
J Pharmacol Exp Ther; 1985 Feb; 232(2):439-44. PubMed ID: 2982011
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
[TBL] [Abstract][Full Text] [Related]
14. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.
Koek W; Colpaert FC; Vignon J
J Pharmacol Exp Ther; 1993 Feb; 264(2):746-56. PubMed ID: 8437123
[TBL] [Abstract][Full Text] [Related]
15. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
France CP; Woods JH
J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
[TBL] [Abstract][Full Text] [Related]
16. Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone.
Gerrits MA; Kuzmin AV; van Ree JM
Eur Neuropsychopharmacol; 2005 May; 15(3):297-303. PubMed ID: 15820419
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
18. Morphine, saline and naltrexone discrimination in morphine-treated pigeons.
France CP; Woods JH
J Pharmacol Exp Ther; 1987 Jul; 242(1):195-202. PubMed ID: 3612524
[TBL] [Abstract][Full Text] [Related]
19. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
France CP; Woods JH
J Pharmacol Exp Ther; 1989 Sep; 250(3):937-43. PubMed ID: 2550623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
